US SB2209 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Republican 2-1)
Status: Introduced on June 24 2021 - 25% progression, died in committee
Action: 2021-06-24 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 24 2021 - 25% progression, died in committee
Action: 2021-06-24 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Title
VALID Act of 2021 Verifying Accurate Leading-edge IVCT Development Act of 2021
Sponsors
| Sen. Richard Burr [R-NC] | Sen. Michael Bennet [D-CO] | Sen. Mike Braun [R-IN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-06-24 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB4128 (Same As) 2021-06-25 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/2209/all-info |
| Text | https://www.congress.gov/117/bills/s2209/BILLS-117s2209is.pdf |
